2022 preview: Expect a row over controversial Alzheimer's drug

In 2021, the US approved the first drug designed to treat the cause of Alzheimer's, but the European Union rejected it. Whether the drug can actually treat the chief symptoms of the disease will be a point of contention in 2022

Landwebs Landwebs
Jan 3, 2022 - 08:00
0 7
2022 preview: Expect a row over controversial Alzheimer's drug
In 2021, the US approved the first drug designed to treat the cause of Alzheimer's, but the European Union rejected it. Whether the drug can actually treat the chief symptoms of the disease will be a point of contention in 2022
Read More